Back
Verrica Pharmaceuticals Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
20
VRCA
Verrica Pharmaceuticals
Last Price:
0.83
Seasonality Move:
34.27%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Verrica Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.13 | Sell |
| 20-day SMA: | 1.36 | Sell |
| 50-day SMA: | 1.6 | Sell |
| 200-day SMA: | 5.25 | Sell |
| 8-day EMA: | 1.04 | Sell |
| 20-day EMA: | 1.29 | Sell |
| 50-day EMA: | 1.97 | Sell |
| 200-day EMA: | 4.31 | Sell |
Verrica Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 31.66 | Sell |
| Chaikin Money Flow: | 1605488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.07 - 1.63) | Sell |
| Bollinger Bands (100): | (1.18 - 6.5) | Sell |
Verrica Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Verrica Pharmaceuticals Stock
Is Verrica Pharmaceuticals Stock a Buy?
- Verrica Pharmaceuticals share price is 0.83 while VRCA 8-day simple moving average is 1.13, which is a Sell signal.
- The stock price of VRCA is 0.83 while Verrica Pharmaceuticals 20-day SMA is 1.36, which makes it a Sell.
- Verrica Pharmaceuticals 50-day simple moving average is 1.60 while VRCA share price is 0.83, making it a Sell technically.
- VRCA stock price is 0.83 and Verrica Pharmaceuticals 200-day simple moving average is 5.25, creating a Sell signal.
VRCA Technical Analysis vs Fundamental Analysis
Sell
20
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy or a Sell?
-
Verrica Pharmaceuticals stock is rated a Sell
The current Verrica Pharmaceuticals [VRCA] share price is $0.83. The Score for VRCA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Verrica Pharmaceuticals Stock Info
Market Cap:
37.84M
Price in USD:
0.83
Share Volume:
1.61M
Verrica Pharmaceuticals 52-Week Range
52-Week High:
11.41
52-Week Low:
0.70
Sell
20
Verrica Pharmaceuticals (VRCA)
is a Sell
Verrica Pharmaceuticals Share Price Forecast
-
What is the Verrica Pharmaceuticals stock price today?
The Verrica Pharmaceuticals stock price is 0.83 USD today. -
Will VRCA stock go up or go down?
Verrica Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Verrica Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verrica Pharmaceuticals is overvalued.
Is Verrica Pharmaceuticals Stock a Buy?
- Verrica Pharmaceuticals share price is 0.83 while VRCA 8-day exponential moving average is 1.04, which is a Sell signal.
- The stock price of VRCA is 0.83 while Verrica Pharmaceuticals 20-day EMA is 1.29, which makes it a Sell.
- Verrica Pharmaceuticals 50-day exponential moving average is 1.97 while VRCA share price is 0.83, making it a Sell technically.
- VRCA stock price is 0.83 and Verrica Pharmaceuticals 200-day simple moving average is 4.31, creating a Sell signal.
Fundamental Analysis of Verrica Pharmaceuticals
Is Verrica Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.73 per share.
Technical Analysis of Verrica Pharmaceuticals
Should I short Verrica Pharmaceuticals stock?
- VRCA Moving Average Covergence Divergence (MACD) indicator is -0.24, suggesting Verrica Pharmaceuticals is a Sell
- Verrica Pharmaceuticals Relative Strength Index (RSI) is 31.66, which suggest Verrica Pharmaceuticals is oversold
- The Bollinger Bands (25) for Verrica Pharmaceuticals is (1.07 - 1.63), which suggest Verrica Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Verrica Pharmaceuticals is (1.18 - 6.5), which suggest Verrica Pharmaceuticals is a Sell
* Verrica Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.